557 related articles for article (PubMed ID: 16236334)
41. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.
Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H
Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631
[TBL] [Abstract][Full Text] [Related]
42. In vitro characterization of novel NR2B selective NMDA receptor antagonists.
Kiss L; Cheng G; Bednar B; Bednar RA; Bennett PB; Kane SA; McIntyre CJ; McCauley JA; Koblan KS
Neurochem Int; 2005 May; 46(6):453-64. PubMed ID: 15769547
[TBL] [Abstract][Full Text] [Related]
43. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors.
Kloda A; Clements JD; Lewis RJ; Adams DJ
Mol Pharmacol; 2004 Jun; 65(6):1386-96. PubMed ID: 15155832
[TBL] [Abstract][Full Text] [Related]
44. An N-methyl-D-aspartate receptor mediated large, low-frequency, spontaneous excitatory postsynaptic current in neonatal rat spinal dorsal horn neurons.
Thomson LM; Zeng J; Terman GW
Neuroscience; 2006 Sep; 141(3):1489-501. PubMed ID: 16750886
[TBL] [Abstract][Full Text] [Related]
45. Design of antagonists for NMDA and AMPA receptors.
Bolshakov KV; Kim KH; Potapjeva NN; Gmiro VE; Tikhonov DB; Usherwood PN; Mellor IR; Magazanik LG
Neuropharmacology; 2005 Aug; 49(2):144-55. PubMed ID: 15996563
[TBL] [Abstract][Full Text] [Related]
46. Different capacities of various NMDA receptor antagonists to prevent ischemia-induced neurodegeneration in human cultured NT2 neurons.
Garcia de Arriba S; Wegner F; Grüner K; Verdaguer E; Pallas M; Camins A; Wagner A; Wohlfahrt K; Allgaier C
Neurochem Int; 2006 Oct; 49(5):466-74. PubMed ID: 16650914
[TBL] [Abstract][Full Text] [Related]
47. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
48. Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons.
Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T
J Pharmacol Exp Ther; 2003 Oct; 307(1):160-7. PubMed ID: 12805478
[TBL] [Abstract][Full Text] [Related]
49. Selective neurotoxicity induced by the ionophore lasalocid in rat dissociated cerebral cultures, involvement of the NMDA receptor/channel.
Safran N; Haring R; Gurwitz D; Shainberg A; Halili I; Levy A; Bogin E; Shahar A
Neurotoxicology; 1996; 17(3-4):883-95. PubMed ID: 9086512
[TBL] [Abstract][Full Text] [Related]
50. Postnatal switching of NMDA receptor subunits from NR2B to NR2A in rat facial motor neurons.
Xing GG; Wang R; Yang B; Zhang D
Eur J Neurosci; 2006 Dec; 24(11):2987-92. PubMed ID: 17156360
[TBL] [Abstract][Full Text] [Related]
51. Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro.
Lupp A; Lücking CH; Koch R; Jackisch R; Feuerstein TJ
J Pharmacol Exp Ther; 1992 Nov; 263(2):717-24. PubMed ID: 1359111
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of hyperpolarization-activated cation currents by phencyclidine and some sigma ligands in rat hippocampal CA1 pyramidal neurons in vitro.
Tanabe M
Neuropharmacology; 2007 Sep; 53(3):406-14. PubMed ID: 17631922
[TBL] [Abstract][Full Text] [Related]
53. Tonic facilitation of glutamate release by glycine binding sites on presynaptic NR2B-containing NMDA autoreceptors in the rat visual cortex.
Li YH; Han TZ; Meng K
Neurosci Lett; 2008 Feb; 432(3):212-6. PubMed ID: 18248890
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological characterization of inward current evoked by N-methyl-D-aspartate in dopamine neurons in the rat brain slice.
Wu YN; Johnson SW
J Pharmacol Exp Ther; 1996 Nov; 279(2):457-63. PubMed ID: 8930146
[TBL] [Abstract][Full Text] [Related]
55. [Effect of the potential antiparkinsonian agent adamantane derivative on ion channels of NMDA glutamate receptors].
Elshanskaia MV; Sobolevskiĭ AI; Val'dman EA; Khodorov BI
Eksp Klin Farmakol; 2001; 64(1):18-21. PubMed ID: 11544796
[TBL] [Abstract][Full Text] [Related]
56. Excitotoxicity in vitro by NR2A- and NR2B-containing NMDA receptors.
von Engelhardt J; Coserea I; Pawlak V; Fuchs EC; Köhr G; Seeburg PH; Monyer H
Neuropharmacology; 2007 Jul; 53(1):10-7. PubMed ID: 17570444
[TBL] [Abstract][Full Text] [Related]
57. Changes in secondary glutamate release underlie the developmental regulation of excitotoxic neuronal cell death.
Fogal B; Trettel J; Uliasz TF; Levine ES; Hewett SJ
Neuroscience; 2005; 132(4):929-42. PubMed ID: 15857699
[TBL] [Abstract][Full Text] [Related]
58. Kinetics and subunit composition of NMDA receptors in respiratory-related neurons.
Paarmann I; Frermann D; Keller BU; Villmann C; Breitinger HG; Hollmann M
J Neurochem; 2005 May; 93(4):812-24. PubMed ID: 15857385
[TBL] [Abstract][Full Text] [Related]
59. Serotonin modulation of cell excitability and of [3H]GABA and [3H]D-aspartate efflux in primary cultures of rat cortical neurons.
Bianchi C; Marani L; Marino S; Barbieri M; Nazzaro C; Beani L; Siniscalchi A
Neuropharmacology; 2007 Mar; 52(3):995-1002. PubMed ID: 17156800
[TBL] [Abstract][Full Text] [Related]
60. Glycine receptors mediate excitation of subplate neurons in neonatal rat cerebral cortex.
Kilb W; Hanganu IL; Okabe A; Sava BA; Shimizu-Okabe C; Fukuda A; Luhmann HJ
J Neurophysiol; 2008 Aug; 100(2):698-707. PubMed ID: 18562558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
